Evidence map›Paper›PMID 32971255›Full record

ReviewAgeing research reviews2020

A research agenda for ageing in China in the 21st century (2nd edition): Focusing on basic and translational research, long-term care, policy and social networks.

Evandro F Fang, Chenglong Xie, Joseph A Schenkel, Chenkai Wu, Qian Long, Honghua Cui, Yahyah Aman, Johannes Frank, Jing Liao, Huachun Zou and 22 more

Open access · greenAbstract readReview
In one paragraph

Review in Ageing research reviews, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 355 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
355citing papers in PubMed, 4 pooled it
31.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

355 citing papers in PubMed, 4 syntheses or guidelines pooled it, 639 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Review
  8. Persisting predominant clinical CC87Emerging microbes & infections · 2026
    Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. A combined artificial intelligence-wet lab approach identifies a pivotal role of the NADAlzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

295 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors at 16 institutions in 7 countries.

Evandro F FangDepartment of Clinical Molecular Biology, University of Oslo and Akershus University Hospital, 1478 Lørenskog, Norway; The Norwegian Centre on Healthy Ageing (NO-Age), Oslo, Norway; Department of Hypertension and Vascular Disease, The First Affiliated Hospital, Sun Yat-Sen University, 510080, Guangzhou, China; Institute of Geriatric Immunology, School of Medicine, Jinan University, 510632, Guangzhou, China; Department of Geriatrics, The First Affiliated Hospital, Zhengzhou University, 450052, Zhengzhou, China. Electronic address: e.f.fang@medisin.uio.no.
Chenglong XieDepartment of Clinical Molecular Biology, University of Oslo and Akershus University Hospital, 1478 Lørenskog, Norway; Department of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China. Electronic address: xiechenglong1987@126.com.
Joseph A SchenkelDurham University Department of Sports and Exercise Sciences, Durham, United Kingdom. Electronic address: j.a.schenkel@durham.ac.uk.
Chenkai WuGlobal Health Research Center, Duke Kunshan University, 215316, Kunshan, China; Duke Global Health Institute, Duke University, Durham, 27710, North Carolina, USA. Electronic address: chenkai.wu@dukekunshan.edu.cn.
Qian LongGlobal Health Research Center, Duke Kunshan University, 215316, Kunshan, China. Electronic address: qian.long@dukekunshan.edu.cn.
Honghua CuiDepartment of Endodontics, Shanghai Stomatological Hospital, Fudan University, China; Oral Biomedical Engineering Laboratory, Shanghai Stomatological Hospital, Fudan University, China. Electronic address: hongh_cui@126.com.
Yahyah AmanDepartment of Clinical Molecular Biology, University of Oslo and Akershus University Hospital, 1478 Lørenskog, Norway. Electronic address: yahyah.aman@medisin.uio.no.
Johannes FrankDepartment of Clinical Molecular Biology, University of Oslo and Akershus University Hospital, 1478 Lørenskog, Norway. Electronic address: jfrank0990@gmail.com.
Jing LiaoDepartment of Medical Statistics and Epidemiology, School of Public Health, Sun Yat-sen University, 510275, Guangzhou, China; Sun Yat-sen Global Health Institute, Institute of State Governance, Sun Yat-sen University, 510275, Guangzhou, China. Electronic address: liaojing5@mail.sysu.edu.cn.
Huachun ZouSchool of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, China; Kirby Institute, University of New South Wales, Sydney, Australia. Electronic address: zouhuachun@mail.sysu.edu.cn.
Ninie Y WangPinetree Care Group, 515 Tower A, Guomen Plaza, Chaoyang District, 100028, Beijing, China. Electronic address: ninie.wang@pinetreecare.com.
Jing WuDepartment of Sociology and Work Science, University of Gothenburg, SE-405 30, Gothenburg, Sweden. Electronic address: jing.wu@gu.se.
Xiaoting LiuSchool of Public Affairs, Zhejiang University, Hangzhou, 310058, Zhejiang, China. Electronic address: xtliu@zju.edu.cn.
Tao LiBGI-Shenzhen, Beishan Industrial Zone, 518083, Shenzhen, China; China National GeneBank, BGI-Shenzhen, 518120, Shenzhen, China. Electronic address: litao2@genomics.cn.
Yuan FangDepartment of Public Health, Erasmus University Medical Centre, Rotterdam, the Netherlands. Electronic address: y.fang@erasmusmc.nl.
Zhangming NiuAladdin Healthcare Technologies Ltd., 25 City Rd, Shoreditch, London EC1Y 1AA, UK. Electronic address: zhangming@aladdinid.com.
Guang YangCardiovascular Research Centre, Royal Brompton Hospital, London, SW3 6NP, UK; and National Heart and Lung Institute, Imperial College London, London, SW7 2AZ, United Kingdom. Electronic address: g.yang@imperial.ac.uk.
Jiangshui HongMindrank AI, Hangzhou, Zhejiang Province, China. Electronic address: emailofwalter@gmail.com.
Qian WangDepartment of Geriatrics, The First Affiliated Hospital, Zhengzhou University, 450052, Zhengzhou, China. Electronic address: qiansmile320@163.com.
Guobing ChenInstitute of Geriatric Immunology, School of Medicine, Jinan University, 510632, Guangzhou, China. Electronic address: guobingchen@jnu.edu.cn.
Jun LiDepartment of Biochemistry and Molecular Biology, The Institute of Basic Medical Sciences, The Chinese Academy of Medical Sciences (CAMS)& Peking Union Medical University (PUMC), 5 Dondan Santiao Road, Beijing, 100730, China. Electronic address: jun_li@ibms.pumc.edu.cn.
Hou-Zao ChenDepartment of Biochemistry and Molecular Biology, The Institute of Basic Medical Sciences, The Chinese Academy of Medical Sciences (CAMS)& Peking Union Medical University (PUMC), 5 Dondan Santiao Road, Beijing, 100730, China. Electronic address: chenhouzao@ibms.cams.cn.
Lin KangDepartment of Geriatrics, Peking Union Medical College Hospital, Beijing, 100730, China. Electronic address: kanglin_66@126.com.
Huanxing SuState Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao. Electronic address: huanxingsu@um.edu.mo.
Brian C GilmourThe Norwegian Centre on Healthy Ageing (NO-Age), Oslo, Norway. Electronic address: briancg@student.ibv.uio.no.
Xinqiang ZhuDepartment of Toxicology, Zhejiang University School of Public Health, Hangzhou, 310058, Zhejiang, China; The Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu, 322000, Zhejiang, China. Electronic address: zhuxq@zju.edu.cn.
Hong JiangDepartment of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China; Key Laboratory of Hunan Province in Neurodegenerative Disorders, Central South University, Changsha, Hunan, China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China. Electronic address: jianghong73868@126.com.
Na HeSchool of Public Health, Fudan University, 200032, Shanghai, China; Key Laboratory of Public Health Safety of Ministry of Education, Fudan University, 200032, Shanghai, China; Key Laboratory of Health Technology Assessment of Ministry of Health, Fudan University, 200032, Shanghai, China. Electronic address: nhe@fudan.edu.cn.
Jun TaoDepartment of Hypertension and Vascular Disease, The First Affiliated Hospital, Sun Yat-Sen University, 510080, Guangzhou, China. Electronic address: taojungz123@163.com.
Sean Xiao LengDivision of Geriatric Medicine and Gerontology, Johns Hopkins University School of Medicine, 5505 Hopkins Bayview Circle, Baltimore, MD 21224, USA. Electronic address: sleng1@jhmi.edu.
Tanjun TongResearch Center on Ageing, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing Key Laboratory of Protein Posttranslational Modifications and Cell Function, Beijing, China. Electronic address: ttj@bjmu.edu.cn.
Jean WooDepartment of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China. Electronic address: jeanwoowong@cuhk.edu.hk.
China National GeneBank · CNJinan University · CNUniversity of Oslo · NOAkershus University Hospital · NODuke Kunshan University · CNDuke University · USDurham University · GBErasmus University Rotterdam · NLFirst Affiliated Hospital of Zhengzhou University · CNFudan University · CNRoyal Brompton Hospital · GBSun Yat-sen University · CNThe First Affiliated Hospital, Sun Yat-sen University · CNUniversity of Gothenburg · SEUNSW Sydney · AUZhejiang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

One of the key issues facing public healthcare is the global trend of an increasingly ageing society which continues to present policy makers and caregivers with formidable healthcare and socio-economic challenges. Ageing is the primary contributor to a broad spectrum of chronic disorders all associated with a lower quality of life in the elderly. In 2019, the Chinese population constituted 18 % of the world population, with 164.5 million Chinese citizens aged 65 and above (65+), and 26 million aged 80 or above (80+). China has become an ageing society, and as it continues to age it will continue to exacerbate the burden borne by current family and public healthcare systems. Major healthcare challenges involved with caring for the elderly in China include the management of chronic non-communicable diseases (CNCDs), physical frailty, neurodegenerative diseases, cardiovascular diseases, with emerging challenges such as providing sufficient dental care, combating the rising prevalence of sexually transmitted diseases among nursing home communities, providing support for increased incidences of immune diseases, and the growing necessity to provide palliative care for the elderly. At the governmental level, it is necessary to make long-term strategic plans to respond to the pressures of an ageing society, especially to establish a nationwide, affordable, annual health check system to facilitate early diagnosis and provide access to affordable treatments. China has begun work on several activities to address these issues including the recent completion of the of the Ten-year Health-Care Reform project, the implementation of the Healthy China 2030 Action Plan, and the opening of the National Clinical Research Center for Geriatric Disorders. There are also societal challenges, namely the shift from an extended family system in which the younger provide home care for their elderly family members, to the current trend in which young people are increasingly migrating towards major cities for work, increasing reliance on nursing homes to compensate, especially following the outcomes of the 'one child policy' and the 'empty-nest elderly' phenomenon. At the individual level, it is important to provide avenues for people to seek and improve their own knowledge of health and disease, to encourage them to seek medical check-ups to prevent/manage illness, and to find ways to promote modifiable health-related behaviors (social activity, exercise, healthy diets, reasonable diet supplements) to enable healthier, happier, longer, and more productive lives in the elderly. Finally, at the technological or treatment level, there is a focus on modern technologies to counteract the negative effects of ageing. Researchers are striving to produce drugs that can mimic the effects of 'exercising more, eating less', while other anti-ageing molecules from molecular gerontologists could help to improve 'healthspan' in the elderly. Machine learning, 'Big Data', and other novel technologies can also be used to monitor disease patterns at the population level and may be used to inform policy design in the future. Collectively, synergies across disciplines on policies, geriatric care, drug development, personal awareness, the use of big data, machine learning and personalized medicine will transform China into a country that enables the most for its elderly, maximizing and celebrating their longevity in the coming decades. This is the 2nd edition of the review paper (Fang EF et al., Ageing Re. Rev. 2015).

Indexed as

Long-Term CareQuality of LifeAdolescentAgedAged, 80 and overAgingChinaHumansPolicySocial NetworkingTranslational Research, BiomedicalAgeing policyDementiaInflammageingOral ageingSexually transmitted diseasesSquare dancing

Identifiers

PMID32971255
PMCPMC7505078
OpenAlexW3088203460

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.